A 35-year-old man was admitted with fever (38°C), mucous sputum, bilateral conjunctivitis, painful oral ulcerations and mild discomfort while urinating. He had previously received a three-day course of azithromycin for suspected respiratory infection, without improvement. Physical examination showed bilateral conjunctivitis with severe subconjunctival hemorrhage (Figure 1) and markedly swollen, erythematous lips with oral ulcers (Appendix 1, available at www.cmaj.ca/lookup/suppl/doi:10.1503/cmaj.151017/-/DC1). The skin was not involved. Laboratory examination showed leukocytosis with neutrophilia and marked elevation of C-reactive protein. Serologic tests for herpes simplex virus, HIV, Epstein–Barr virus and Treponema pallidum yielded negative results, but positive titres were found for Mycoplasma pneumoniae immunoglobulins M and G. Mycoplasma pneumoniae–associated mucositis was diagnosed. Initiation of intravenous treatment with corticosteroids (tapered methylprednisolone, starting with 125 mg daily) led to remarkably rapid improvement in the ocular, oral and urinary symptoms and complete resolution of the lesions within three weeks.
Figure 1:
Bilateral conjunctivitis with severe subconjunctival hemorrhage and erythematous lips in a 35-year-old man.
Mycoplasma pneumoniae, a common cause of community-acquired atypical pneumonia, may lead to associated extrapulmonary complications, including skin manifestations such as erythema multiforme major, in up to 25% of patients.1 Cases of M. pneumoniae infection characterized by mucositis consistent with erythema multiforme major but without skin lesions have gone by various terms, including “Fuchs syndrome” and “M. pneumoniae–associated mucositis.”1 Some authors have suggested that the latter be considered a distinct syndrome, because of its milder disease course, infrequent long-term sequelae and exceedingly rare mortality.1,2 The condition affects predominantly children and adolescents; only a few cases with adult onset have been reported,3 perhaps because the disease is underrecognized or milder in this age group.
There are no evidence-based guidelines for treatment of M. pneumoniae–associated mucositis.1 Empiric antibiotic therapy is an effective first-line approach.3 Systemic corticosteroids and intravenous immunoglobulins may limit disease duration and severity and should be considered in severe cases, to limit the potential for complications associated with mucous membrane adhesions, especially ocular sequelae.
Clinical images are chosen because they are particularly intriguing, classic or dramatic. Submissions of clear, appropriately labelled high-resolution images must be accompanied by a figure caption and the patient’s written consent for publication. A brief explanation (250 words maximum) of the educational significance of the images with minimal references is required.
Footnotes
Competing interests: None declared.
This article has been peer reviewed.
The authors have obtained patient consent.
References
- 1.Canavan TN, Mathes EF, Frieden I, et al. Mycoplasma pneumoniae–induced rash and mucositis as a syndrome distinct from Stevens–Johnson syndrome and erythema multiforme: a systematic review. J Am Acad Dermatol 2015;72:239–45. [DOI] [PubMed] [Google Scholar]
- 2.Vujic I, Shroff A, Grzelka M, et al. Mycoplasma pneumoniae–associated mucositis — case report and systematic review of literature. J Eur Acad Dermatol Venereol 2015;29:595–8. [DOI] [PubMed] [Google Scholar]
- 3.Meyer Sauteur PM, Goetschel P, Lautenschlager S. Mycoplasma pneumoniae and mucositis — part of the Stevens–Johnson syndrome spectrum. J Dtsch Dermatol Ges 2012; 10:740–6. [DOI] [PubMed] [Google Scholar]